William S. Dalton
William S. Dalton is the chair of the IHMC Board of Directors. He is also Founder and CEO of M2GenĀ®, a national biotechnology subsidiary of Moffitt Cancer Center. Dr. Dalton received his Ph.D. in toxicology and medical life sciences and his M.D. degree from Indiana University. He is interested in developing approaches to enhance access to health care and developing evidence-based methods of evaluating and integrating new technologies into the standard of care.
Latest News
- Air Force Academy’s Cadet Summer Research Program interns find home at IHMC
- STEM-Talk: Charles Serhan, expert on specialized pro-resolving mediators, talks inflammation
- IHMC partners with California-based research institute to take aim at the psychology of cyber attackers
- STEM-Talk: Dave Feldman on the Citizen Science Foundation, ketogenic diet research
- New biomedical research complex opens IHMC’s next chapter
- Triumph Gulf Coast funding will help bolster research capabilities at Pensacola campus
- IHMC Robert Griffin represents the America on IEEE Technical Committee
- STEM-Talk: Alessio Fasano on the roots of, treatments for celiac disease
- IHMC hosts the IGNITE event for the NATO Innovation Continuum